Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 4801 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 4802 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 72 |
| 4803 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 4804 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 4805 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 4806 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 48 |
| 4807 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 4808 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 4809 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2018 | Standard Therapy | Germany | 51 |
| 4810 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 4811 | Apheresis | Allogeneic | Other Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 4812 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 4813 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 4814 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 4815 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 4816 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 4817 | Apheresis | Allogeneic | Post-Essential Thrombocythemia-Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 53 |
| 4818 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 4819 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 4820 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 4821 | Apheresis | Autologous | Primary Central Nervous System Lymphoma Relapse | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 4822 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 4823 | Apheresis | Allogeneic | Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
| 4824 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 4825 | Apheresis | Autologous | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 36 |
| 4826 | Apheresis | Allogeneic | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 50 |
| 4827 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 4828 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
| 4829 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Primary Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 56 |
| 4830 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
| 4831 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 74 |
| 4832 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
| 4833 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 4834 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 4835 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
| 4836 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 4837 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 |
| 4838 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
| 4839 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 4840 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
| 4841 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 4842 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 4843 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 23 |
| 4844 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 5 |
| 4845 | Apheresis | Allogeneic | Therapy-Related Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 4846 | Adipose Tissue | Autologous | Condition After Injury Of The Left Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 33 |
| 4847 | Adipose Tissue | Autologous | Coxarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 53 |
| 4848 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4849 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4850 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4851 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4852 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4853 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4854 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4855 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4856 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 69 |
| 4857 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 42 |
| 4858 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4859 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4860 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4861 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4862 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4863 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4864 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4865 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4866 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4867 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4868 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | no data |
| 4869 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 44,2 |
| 4870 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 25,8 |
| 4871 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 38,5 |
| 4872 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 26,1 |
| 4873 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 37,11 |
| 4874 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 62,5 |
| 4875 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 35,4 |
| 4876 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 31,3 |
| 4877 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 13 |
| 4878 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 11,1 |
| 4879 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 2,4 |
| 4880 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 8,1 |
| 4881 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 7,6 |
| 4882 | Cord Tissue | Allogeneic – Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2017 | Experimental Therapy | Poland | 33,4 |
| 4883 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 67,11 |
| 4884 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 37,9 |
| 4885 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 71,7 |
| 4886 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | no data |
| 4887 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 47,6 |
| 4888 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
| 4889 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 48,11 |
| 4890 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46,3 |
| 4891 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 45,9 |
| 4892 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 75,9 |
| 4893 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51,3 |
| 4894 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59,8 |
| 4895 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 64,9 |
| 4896 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56,7 |
| 4897 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 40,11 |
| 4898 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 69,1 |
| 4899 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 52 |
| 4900 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 35,1 |